- Prothena Reports First Quarter 2024 Financial Results and Business Highlights
- Prothena to Report First Quarter 2024 Financial Results on May 8
- Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
- Prothena to Participate in Upcoming Healthcare Conferences
Key statistics
On Thursday, Prothena Corporation PLC (PRTA:NSQ) closed at 20.10, 2.29% above its 52-week low of 19.65, set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 21.66 |
---|---|
High | 21.66 |
Low | 19.78 |
Bid | 19.50 |
Offer | 21.00 |
Previous close | 21.59 |
Average volume | 456.41k |
---|---|
Shares outstanding | 53.77m |
Free float | 47.09m |
P/E (TTM) | -- |
Market cap | 1.08bn USD |
EPS (TTM) | -3.25 USD |
Data delayed at least 15 minutes, as of May 23 2024 21:00 BST.
More ▼